Sponsor or institution
Clinical trials and research at Hellenic Institute for the Study of Sepsis
As of November 12, 2026, Find a Trial lists 6 clinical trials run by Hellenic Institute for the Study of Sepsis that are recruiting, at sites in 4 countries (most in Greece (6), Germany (1), Italy (1)). By phase: Phase 3 (3), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 4Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Clarithromycin to help prevent secondary infections in adults with pneumonia and sepsis | Phase 3 | Pátrai, Achaea and 18 other locations | Recruiting | Sep 22, 2026 |
| Early PSP-guided Meropenem in at-risk adults with suspected infection | Phase 3 | Athens, Attica and 9 other locations | Recruiting | Sep 10, 2026 |
| Investigating long-term complications of COVID-19 on lungs, heart, and kidneys | — | Athens and 5 other locations | Recruiting | Sep 23, 2024 |
| Investigating cardiovascular disease progression in pneumonia survivors | — | Alexandroupoli and 18 other locations | Recruiting | Sep 19, 2024 |
| Using clarithromycin to prevent sepsis in pneumonia patients | Phase 3 | Athens, Athens and 23 other locations | Recruiting | Mar 5, 2024 |
| Evaluating Anakinra for Long COVID Symptoms | Phase 2/3 | Jena and 23 other locations | Recruiting | Jul 3, 2023 |
All recruiting trials (6)
-
Clarithromycin to help prevent secondary infections in adults with pneumonia and sepsis
This study tests whether adding clarithromycin to standard antibiotics can reduce new infections and secondary sepsis in adults hospitalized with community-acquired pneumonia and sepsis.
-
Early PSP-guided Meropenem in at-risk adults with suspected infection
This trial tests whether giving a single dose of meropenem based on PSP levels in adults with suspected infection can reduce the risk of sepsis compared to a placebo.
-
Investigating long-term complications of COVID-19 on lungs, heart, and kidneys
This study is trying to see if people who had COVID-19 have more problems with their lungs, heart, and kidneys compared to those who didn't have the virus.
-
Investigating cardiovascular disease progression in pneumonia survivors
This study is trying to see how surviving pneumonia, including COVID-19, affects the risk of heart problems later on.
-
Using clarithromycin to prevent sepsis in pneumonia patients
This study is testing if adding clarithromycin to the treatment of pneumonia can help prevent sepsis in patients who are at risk.
-
Evaluating Anakinra for Long COVID Symptoms
This study is testing if anakinra, an anti-inflammatory medication, can help people with long COVID symptoms feel better.
Quick answers
How many clinical trials run by Hellenic Institute for the Study of Sepsis are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Greece (6 trials), Germany (1 trial), Italy (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.